# Stefan Lorenzl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stefan-lorenzl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,104 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 43 |
| i10-index | 123 |
| Last Known Institution | Paracelsus Medical University |
| OpenAlex ID | https://openalex.org/A5077799149 |
| ORCID iD | 0000-0002-1165-0821 |
| Works | 293 |

## Researcher papers

- [A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease](https://scholariq.org/papers/a-randomized-trial-of-deep-brain-stimulation-for-parkinson-s-disease/)
- [Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria](https://scholariq.org/papers/clinical-diagnosis-of-progressive-supranuclear-palsy-the-movement-disorder/)
- [Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations](https://scholariq.org/papers/dipeptide-repeat-protein-pathology-in-c9orf72-mutation-cases-clinico/)
- [Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial](https://scholariq.org/papers/davunetide-in-patients-with-progressive-supranuclear-palsy-a-randomised-double/)
- [A consensus review on the development of palliative care for patients with chronic and progressive neurological disease](https://scholariq.org/papers/a-consensus-review-on-the-development-of-palliative-care-for-patients-with/)
- [Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease](https://scholariq.org/papers/increased-plasma-levels-of-matrix-metalloproteinase-9-in-patients-with-alzheimer/)
- [Matrix metalloproteinases contribute to the blood—brain barrier disruption during bacterial meningitis](https://scholariq.org/papers/matrix-metalloproteinases-contribute-to-the-blood-brain-barrier-disruption/)
- [A pivotal role of matrix metalloproteinase‐3 activity in dopaminergic neuronal degeneration via microglial activation](https://scholariq.org/papers/a-pivotal-role-of-matrix-metalloproteinase-3-activity-in-dopaminergic-neuronal/)
- [Homocysteine, folate and vitamin B<sub>12</sub>in neuropsychiatric diseases: review and treatment recommendations](https://scholariq.org/papers/homocysteine-folate-and-vitamin-b-sub-12-sub-in-neuropsychiatric-diseases-review/)
- [Which ante mortem clinical features predict progressive supranuclear palsy pathology?](https://scholariq.org/papers/which-ante-mortem-clinical-features-predict-progressive-supranuclear-palsy/)
- [Homecare amyotrophic lateral sclerosis (ALS): A multidisciplinary, home‐based model of care for patients with ALS and their caregivers](https://scholariq.org/papers/homecare-amyotrophic-lateral-sclerosis-als-a-multidisciplinary-home-based-model/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)

## Researcher university

- [Paracelsus Medical University](https://scholariq.org/institutions/paracelsus-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.